Pancreatic endocrine tumors: recent advances

Area of Science:

• Endocrinology
• Oncology
• Molecular Biology

Background:

• Pancreatic endocrine tumors (PETs) encompass ten distinct classes, presenting diverse clinical syndromes.
• PETs share histological and biological similarities with carcinoid tumors, including peptide secretion and vascularity.
• Both tumor types benefit from similar diagnostic and localization techniques, such as somatostatin receptor scintigraphy.

Purpose of the Study:

• To review recent advancements in the diagnosis, localization, and treatment of pancreatic endocrine tumors.
• To discuss the evolving understanding of the molecular basis and natural history of PETs.
• To highlight the dual treatment approach for hormone excess and tumor burden in PETs.

Main Methods:

• Review of recent literature and clinical reports on pancreatic endocrine tumors.
• Analysis of advances in diagnostic imaging and molecular profiling.
• Evaluation of therapeutic strategies, including somatostatin analogues and surgical interventions.

Main Results:

• Significant progress has been made in tumor diagnosis and localization methods.
• Synthetic somatostatin analogues and surgical procedures play key roles in management.
• Insights into the long-term natural history and molecular basis of both inherited and sporadic PETs have been gained.

Conclusions:

• Pancreatic endocrine tumors require tailored treatment strategies addressing both hormonal and neoplastic aspects.
• Continued research into molecular mechanisms and natural history will further refine prognostic factors and treatment planning.
• Advances in diagnostics and therapeutics offer improved management options for patients with PETs.